DAB2IP and hepatocellular carcinoma: Based on these results, we inferred that tRF‐34‐P4R8YP9LON4VHM could activate MEK/ERK phosphorylation and participate in the modulation of VEGFA expression changes by regulating DAB2IP expression, thereby promoting the malignant biological processes of HCC.